{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:19:41Z","timestamp":1790270381488,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common fever syndrome in childhood. High disease activity (DA) dramatically impacts the health-related quality of life. Thus, effective and safe treatment is crucial. Colchicine might be effective, but data are still lacking. Study aimed to assess colchicine safety and effectiveness in PFAPA.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This single center study was conducted between 03\/2012 and 05\/2021 in PFAPA patients without variants in genetic panel testing aged \u2264 18 years fulfilling Marshall criteria and classification criteria of Gattorno et al. Exclusion criteria were elevated liver enzymes, impaired kidney function, celiac disease, lactose intolerance, previous\/ongoing biologics, known colchicine-intolerance. Demographics, clinical characteristics, treatment, DA, colchicine effectiveness and safety were recorded at baseline, first and last visit. Colchicine was started at 0.5\u20131.0 mg\/day. DA was captured by physician (PGA) and patient\/parent (PPGA) global assessment on a 10 cm visual analog scale, categorized as mild (&amp;lt;2), moderate (2\u20134), and high (\u22655). Adverse event (AE) monitoring included gastrointestinal symptoms, liver enzyme\/creatinine elevation, leukopenia, neutropenia. Primary outcome included response (R; composite of PPGA + PGA decrease \u22652) at last follow-up. Secondary outcomes were partial response (PR; PGA decrease = 1 + PPGA decrease \u22651), no response (NR; unchanged\/worsened PGA\/PPGA), colchicine safety, flare characteristics.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-seven PFAPA patients were included, 52% were female, median age was 5.8 years (1\u201310.75), median follow-up time was 13 months. At baseline, median PPGA was high; median PGA moderate. All patients had febrile flares. Median flare frequency was every 4\u20135 weeks; median duration 5\u20136 days. Nine patients were pre-treated with corticosteroids, increasing flare frequency in 8\/9. Primary Outcome: 17 patients (63%) were responders. Secondary outcomes: PR was achieved in 15%; NR in 22% at last follow-up. DA decreased significantly (<jats:italic>p<\/jats:italic> &amp;lt;0.0001). At last follow-up, 52% reported no flares, median flare duration decreased to 1\u20132 days. At first follow-up, 22% reported mild abdominal pain\/diarrhea. Moderate abdominal pain\/diarrhea occurred with \u22651 mg\/day. Mild asymptomatic liver enzyme elevation or leucopenia were rare; no severe AE or colchicine discontinuation were observed.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Colchicine seems to be safe, well-tolerated, and effective in PFAPA patients. It can be considered in children with moderate\/high DA even those without corticosteroid-benefit.<\/jats:p>","DOI":"10.3389\/fped.2021.759664","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:14:59Z","timestamp":1638317699000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Tatjana","family":"Welzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Ellinghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Wildermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin B.","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10067-018-4361-2","article-title":"Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review","volume":"38","author":"Gaggiano","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0022-3476(99)70321-5","article-title":"Periodic fever syndrome in children","volume":"135","author":"Thomas","year":"1999","journal-title":"J Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12887-019-1458-y","article-title":"From uncertainty to gradually managing and awaiting recovery of a periodic condition- a qualitative study of parents experiences of PFAPA syndrome","volume":"19","author":"Sparud-Lundin","year":"2019","journal-title":"BMC Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13023-018-0878-3","article-title":"Health-related quality of life in children with PFAPA syndrome","volume":"13","author":"Grimwood","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12969-020-00424-x","article-title":"Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group","volume":"18","author":"Amarilyo","year":"2020","journal-title":"Pediatr Rheumatol Online J."},{"key":"B7","first-page":"980","article-title":"PFAPA syndrome: clinical characteristics and treatment outcomes in a large single-centre cohort","volume":"31","author":"Krol","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1651-2227.2009.01554.x","article-title":"A clinical review of 105 patients with PFAPA (a periodic fever syndrome)","volume":"99","author":"Feder","year":"2010","journal-title":"Acta Paediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1651-2227.2008.00837.x","article-title":"Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes","volume":"97","author":"Tasher","year":"2008","journal-title":"Acta Paediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.semarthrit.2015.07.005","article-title":"Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome","volume":"45","author":"Butbul","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jbspin.2015.08.017","article-title":"Is colchicine an effective treatment in periodic fever, aphtous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome?","volume":"83","author":"Dusser","year":"2016","journal-title":"Joint Bone Spine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/ped.13265","article-title":"Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?","volume":"59","author":"Gunes","year":"2017","journal-title":"Pediatr Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-3476(87)80285-8","article-title":"Syndrome of periodic fever, pharyngitis, and aphthous stomatitis","volume":"110","author":"Marshall","year":"1987","journal-title":"J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD","volume":"75","author":"Kone-Paut","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B17","first-page":"S327","article-title":"ARDIS - arthritis and rheumatism database and information system [abstract]","volume":"42","author":"Kuemmerle-Deschner","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/ard.2010.132613","article-title":"A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference","volume":"70","author":"Piram","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5152\/eurjrheum.2020.20102","article-title":"Colchicine treatment in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: a multicenter study in Spain","volume":"8","author":"Quintana-Ortega","year":"2020","journal-title":"Eur J Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00431-020-03840-z","article-title":"The role of Mediterranean fever gene variants in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome","volume":"180","author":"Yildiz","year":"2021","journal-title":"Eur J Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.semarthrit.2010.06.009","article-title":"The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome","volume":"40","author":"Berkun","year":"2011","journal-title":"Semin Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpeds.2018.08.080","article-title":"Familial Mediterranean fever is commonly diagnosed in children in israel with periodic fever aphthous stomatitis, pharyngitis, and adenitis syndrome","volume":"204","author":"Butbul","year":"2019","journal-title":"J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00296-019-04362-0","article-title":"Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever","volume":"40","author":"Adrovic","year":"2020","journal-title":"Rheumatol Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00296-018-4105-2","article-title":"Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences","volume":"39","author":"Adrovic","year":"2019","journal-title":"Rheumatol Int."},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-021-04827-1","article-title":"Galectin-3: a new biomarker for differentiating periodic fever, adenitis, pharyngitis, aphthous stomatitis (PFAPA) syndrome from familial Mediterranean fever?","volume-title":"Rheumatol Int","author":"Batu","year":"2021"},{"key":"B26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.semarthrit.2019.05.011","article-title":"Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children","volume":"49","author":"Goldberg","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jpeds.2012.05.047","article-title":"Colchicine is a safe drug in children with familial Mediterranean fever","volume":"161","author":"Padeh","year":"2012","journal-title":"J Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","article-title":"Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses","volume":"36","author":"Ferron","year":"1996","journal-title":"J Clin Pharmacol."},{"key":"B30","article-title":"In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Ben-Chetrit","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint Bone Spine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00296-017-3823-1","article-title":"Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients","volume":"38","author":"Haj","year":"2018","journal-title":"Rheumatol Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3389\/fimmu.2020.00865","article-title":"Current therapeutic options for the main monogenic autoinflammatory diseases and PFAPA syndrome: evidence-based approach and proposal of a practical guide","volume":"11","author":"Soriano","year":"2020","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00296-017-3688-3","article-title":"Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome","volume":"37","author":"Manthiram","year":"2017","journal-title":"Rheumatol Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"CD008669","DOI":"10.1002\/14651858.CD008669.pub3","article-title":"Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)","volume":"12","author":"Burton","year":"2019","journal-title":"Cochrane Database System Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12901-017-0049-5","article-title":"The role of tonsillectomy in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome; a literature review","volume":"18","author":"Forsvoll","year":"2018","journal-title":"BMC Ear Nose Throat Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-019-00724-2","article-title":"Immune dysregulation in the tonsillar microenvironment of periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) Syndrome","volume":"40","author":"Luu","year":"2020","journal-title":"J Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00405-020-05943-7","article-title":"Long-term management of patients with PFAPA syndrome","volume":"277","author":"Yildiz","year":"2020","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"Electronic address: easloffice@easloffice","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"B42","unstructured":"CommonTerminology Criteria for Adverse Events v3,.0 (CTCAE). Blood\/Bone Marrow.\n          2006"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.759664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:15:06Z","timestamp":1638317706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.759664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":42,"alternative-id":["10.3389\/fped.2021.759664"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.759664","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"article-number":"759664"}}